Early carotid artery stenting after onset neurologic symptoms

Semin Vasc Surg. 2018 Mar;31(1):15-20. doi: 10.1053/j.semvascsurg.2018.02.001. Epub 2018 Feb 22.

Abstract

Multicenter clinical trials level 1 evidence favors the application of carotid endarterectomy in symptomatic patients, especially the in the elderly cohort. Carotid artery stenting has been proposed as a possible early alternative in selected patients after onset of ipsilateral neurologic symptoms. It is well known that treatment of acute stroke is time-dependent in patients with acute ischemic stroke caused by high-grade stenosis of the internal carotid artery, but intensive medical treatment in conjunction with intervention to improve stroke severity and clinical outcomes has not been established. Two major clinical concerns exist: (1) the risk of hemorrhagic infarction after cerebral revascularization in the acute stage and (2) application of carotid stenting in the acute embolic stage, which may be associated with continued embolic risk after carotid artery stenting compared to carotid endarterectomy, which removes the symptomatic plaque. This review summarizes the indications and results of early carotid artery stenting after onset of neurologic symptoms, considering the new carotid stents and cerebral protection systems available for clinical use and enhanced stenting techniques.

Publication types

  • Review

MeSH terms

  • Carotid Artery Diseases / complications*
  • Carotid Artery Diseases / diagnostic imaging
  • Carotid Artery Diseases / physiopathology
  • Carotid Artery Diseases / therapy*
  • Cerebrovascular Circulation
  • Clinical Decision-Making
  • Endovascular Procedures / adverse effects
  • Endovascular Procedures / instrumentation*
  • Humans
  • Intracranial Embolism / diagnosis
  • Intracranial Embolism / etiology*
  • Intracranial Embolism / physiopathology
  • Prosthesis Design
  • Regional Blood Flow
  • Risk Factors
  • Stents*
  • Stroke / diagnosis
  • Stroke / etiology*
  • Stroke / physiopathology
  • Time Factors
  • Time-to-Treatment*
  • Treatment Outcome